» Articles » PMID: 27455072

Does Anticoagulant Medication Alter Fracture-Healing? A Morphological and Biomechanical Evaluation of the Possible Effects of Rivaroxaban and Enoxaparin Using a Rat Closed Fracture Model

Overview
Journal PLoS One
Date 2016 Jul 26
PMID 27455072
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Low molecular weight heparin (LMWH) is routinely used to prevent thromboembolism in orthopaedic surgery, especially in the treatment of fractures or after joint-replacement. Impairment of fracture-healing due to increased bone-desorption, delayed remodelling and lower calcification caused by direct osteoclast stimulation is a well-known side effect of unfractioned heparin. However, the effect of LMWH is unclear and controversial. Recent studies strongly suggest impairment of bone-healing in-vitro and in animal models, characterized by a significant decrease in volume and quality of new-formed callus. Since October 2008, Rivaroxaban (Xarelto) is available for prophylactic use in elective knee- and hip-arthroplasty. Recently, some evidence has been found indicating an in vitro dose independent reduction of osteoblast function after Rivaroxaban treatment. In this study, the possible influence of Rivaroxaban and Enoxaparin on bone-healing in vivo was studied using a standardized, closed rodent fracture-model. 70 male Wistar-rats were randomized to Rivaroxaban, Enoxaparin or control groups. After pinning the right femur, a closed, transverse fracture was produced. 21 days later, the animals were sacrificed and both femora harvested. Analysis was done by biomechanical testing (three-point bending) and micro CT. Both investigated substances showed histomorphometric alterations of the newly formed callus assessed by micro CT analysis. In detail the bone (callus) volume was enhanced (sign. for Rivaroxaban) and the density reduced. The bone mineral content was enhanced accordingly (sign. for Rivaroxaban). Trabecular thickness was reduced (sign. for Rivaroxaban). Furthermore, both drugs showed significant enlarged bone (callus) surface and degree of anisotropy. In contrast, the biomechanical properties of the treated bones were equal to controls. To summarize, the morphological alterations of the fracture-callus did not result in functionally relevant deficits.

Citing Articles

Treatment of Bone Defects and Nonunion via Novel Delivery Mechanisms, Growth Factors, and Stem Cells: A Review.

Ehlen Q, Costello 2nd J, Mirsky N, Slavin B, Parra M, Ptashnik A ACS Biomater Sci Eng. 2024; 10(12):7314-7336.

PMID: 39527574 PMC: 11632667. DOI: 10.1021/acsbiomaterials.4c01279.


Low molecular weight heparin decreases pro-coagulant activity in clinical MSC products.

Schriner J, Triolo F, Gill B, Cardenas J, Olson S, Cox Jr C Cytotherapy. 2023; 26(2):194-200.

PMID: 38127031 PMC: 11350517. DOI: 10.1016/j.jcyt.2023.11.010.


The Effect of Anticoagulants on Early Implant Failure: A Retrospective Cohort Study.

Chaushu L, Perez N, Botticelli D, Xavier S, Kolerman R, Masri D J Funct Biomater. 2023; 14(4).

PMID: 37103275 PMC: 10144258. DOI: 10.3390/jfb14040186.


The effect of a new oral anticoagulant (Rivaroxaban) on implants pull-out strength. An experimental study in rats.

Kapetanou A, Savvidis M, Potoupnis M, Petsatodis G, Kirkos J, Kapetanos G J Frailty Sarcopenia Falls. 2020; 2(1):1-5.

PMID: 32300674 PMC: 7155293.


Vitamin K and Bone Health: A Review on the Effects of Vitamin K Deficiency and Supplementation and the Effect of Non-Vitamin K Antagonist Oral Anticoagulants on Different Bone Parameters.

Rodriguez-Olleros Rodriguez C, Diaz Curiel M J Osteoporos. 2020; 2019:2069176.

PMID: 31976057 PMC: 6955144. DOI: 10.1155/2019/2069176.


References
1.
Nyman J, Munoz S, Jadhav S, Mansour A, Yoshii T, Mundy G . Quantitative measures of femoral fracture repair in rats derived by micro-computed tomography. J Biomech. 2009; 42(7):891-7. DOI: 10.1016/j.jbiomech.2009.01.016. View

2.
Hak D, Stewart R, Hazelwood S . Effect of low molecular weight heparin on fracture healing in a stabilized rat femur fracture model. J Orthop Res. 2006; 24(4):645-52. DOI: 10.1002/jor.20090. View

3.
Dahlman T . Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin. Am J Obstet Gynecol. 1993; 168(4):1265-70. DOI: 10.1016/0002-9378(93)90378-v. View

4.
Osip S, Butcher M, Young E, Yang L, Shaughnessy S . Differential effects of heparin and low molecular weight heparin on osteoblastogenesis and adipogenesis in vitro. Thromb Haemost. 2004; 92(4):803-10. DOI: 10.1160/TH04-03-0199. View

5.
Kazakia G, Burghardt A, Cheung S, Majumdar S . Assessment of bone tissue mineralization by conventional x-ray microcomputed tomography: comparison with synchrotron radiation microcomputed tomography and ash measurements. Med Phys. 2008; 35(7):3170-9. PMC: 2673562. DOI: 10.1118/1.2924210. View